Brief: Roquefort Therapeutics Files International Phase PCT Patent For Proprietary Anti-Cancer mRNA, RNA Oligonucleotide Therapeutics

Coiled Therapeutics

14/08/2023 07:17

Aug 14 (Reuters) - Roquefort Therapeutics PLC  ROQ.L :
    * ROQUEFORT THERAPTCS.  - EXPANSION OF PATENT PORTFOLIO
    * ROQUEFORT THERAPEUTICS -  ANNOUNCE FILING OF INTERNATIONAL
PHASE
PERCENT PATENT FOR ITS PROPRIETARY ANTI-CANCER MRNA AND RNA
OLIGONUCLEOTIDE THERAPEUTICS

Source text for Eikon:  ID:nRSN1451Ja 
Further company coverage:  ROQ.L 

 ((Reuters.Briefs@thomsonreuters.com;))